Onconetix (ONCO) Proxy Filing summary

Executive summary

• The proxy filing details an annual meeting to vote on key proposals, including director elections, amendments to the equity incentive plan, a reverse stock split, approval of share issuances related to recent acquisitions and financings, auditor ratification, and potential adjournment to solicit additional proxies.

• The company recently acquired Proteomedix AG, making it a wholly owned subsidiary, and issued Series B Preferred Stock convertible into a significant majority of the company's common stock, pending shareholder approval.

• The company is focused on commercializing Proclarix, a prostate cancer diagnostic, and has paused commercialization of ENTADFI due to resource constraints and is exploring strategic alternatives for that asset.

• The company faces substantial financial challenges, including a working capital deficit, accumulated losses, and the need to raise additional capital to continue operations beyond Q3 2024.

• A fairness opinion was provided by H.C. Wainwright & Co., concluding the share exchange for the Proteomedix acquisition was fair from a financial perspective.

Voting matters and shareholder proposals

• Election of two Class III directors for a three-year term.

• Amendment to the 2022 Equity Incentive Plan to increase the share reserve.

• Approval of a reverse stock split at a ratio between 1-for-30 and 1-for-60 to regain Nasdaq compliance.

• Approval of share issuances upon conversion of Series A and Series B Preferred Stock, and for a $5 million private placement (PMX Financing).

• Ratification of EisnerAmper LLP as the independent auditor for 2024.

• Authorization to adjourn the meeting if necessary to solicit more proxies.

Board of directors and corporate governance

• The board consists of five members, with staggered three-year terms and a mix of industry, financial, and scientific expertise.

• All board committees (audit, compensation, nominating/governance) are composed of independent directors.

• The board recommends voting in favor of all proposals.